Vaccination and protection from a lethal viral infection: Identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope
- 1 October 1990
- Vol. 178 (2) , 393-400
- https://doi.org/10.1016/0042-6822(90)90336-p
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1989
- Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expressionVirology, 1989
- Anti‐viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia‐recombinant virus expressing LCMV‐WE nucleoprotein or glycoproteinEuropean Journal of Immunology, 1989
- A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytesNature, 1989
- Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1988
- Arenavirus Gene Structure and OrganizationPublished by Springer Nature ,1987
- In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.The Journal of Experimental Medicine, 1984
- Genomic and Biological Variation among Commonly Used Lymphocytic Choriomeningitis Virus StrainsJournal of General Virology, 1983
- Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.The Journal of Experimental Medicine, 1981
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963